The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion

Journal of Oncology Pharmacy Practice, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2zf43yD
via IFTTT